Sign inGet started

Martins Eduardo Bruno

Insider CIK 1670431 · EIGR SVP, Liver and Infectious Dise · SGMT Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SGMT Sagimet Biosciences Inc. A Award deriv2026-02-192026-02-2088,000— $088,000SEC↗
SGMT Sagimet Biosciences Inc. A Award2026-02-192026-02-2044,000— $0147,296SEC↗
SGMT Sagimet Biosciences Inc. S Sale2026-02-102026-02-123,640$5.36 $19.5K103,296SEC↗
SGMT Sagimet Biosciences Inc. S Sale2025-07-212025-07-238,277$9.13 $75.6K106,936SEC↗
SGMT Sagimet Biosciences Inc. A Award deriv2025-02-062025-02-07138,000— $0138,000SEC↗
SGMT Sagimet Biosciences Inc. A Award2025-02-062025-02-0734,000— $0115,213SEC↗
SGMT Sagimet Biosciences Inc. S Sale2024-07-192024-07-238,357$3.10 $25.9K81,213SEC↗
SGMT Sagimet Biosciences Inc. A Award2023-11-172023-11-2189,570— $089,570SEC↗
SGMT Sagimet Biosciences Inc. A Award deriv2023-07-182023-07-2044,009— $044,009SEC↗
SGMT Sagimet Biosciences Inc. D To issuer deriv2023-07-182023-07-20198,132— $00SEC↗
SGMT Sagimet Biosciences Inc. A Award deriv2023-07-182023-07-20198,132— $0198,132SEC↗
SGMT Sagimet Biosciences Inc. D To issuer deriv2023-07-182023-07-2044,009— $00SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2017-03-092017-03-1430,000— $030,000SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2016-03-232016-09-1565,216— $065,216SEC↗
EIGR Eiger BioPharmaceuticals, A Award deriv2016-03-232016-03-2865,216— $065,216SEC↗